Elicio Therapeutics (ELTX)
Develops AMP-enabled cancer immunotherapies centered on the ELI-002 mutant-KRAS program.
$1.88
vs last close+0.01 (+0.53%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 20.74% | 3.96M shares | |
|---|---|---|---|
| 67 holders · as of Jun 30, 2026 | |||
| Insiders | 52.77% | 10.06M shares | |
| 6 holders · as of Feb 3, 2026 | |||
| Strategic holders | 7.39% | 1.41M shares | |
| 1 holder · as of Jul 16, 2026 | |||
| Other | 19.10% | 3.64M shares | |
| remainder | |||
19.07M company shares as of Aug 30, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (26.28M in the company's Sep 23, 2026 report, 19.07M elsewhere); stakes use the report.
13F, as of Jun 30, 2026
67 holders · 3.96M shares · 31 new positions · 46 increased · 4 reduced · 22 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Knoll Capital Management, LLC | 1.21M | 6.36% | +581.0K | Sep 10, 2026 |
| BlackRock, Inc. | 766.0K | 4.02% | +715.4K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 572.2K | 3.00% | +53.5K | Aug 13, 2026 |
| Geode Capital Management, LLC | 311.4K | 1.63% | +176.2K | Aug 12, 2026 |
| State Street Corp | 179.4K | 0.94% | +128.8K | Aug 7, 2026 |
| Northern Trust Corp | 130.2K | 0.68% | +70.4K | Aug 13, 2026 |
| Ikarian Capital, LLC | 100.0K | 0.52% | +100.0Knew | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 88.9K | 0.47% | +88.9Knew | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Yekaterina Chudnovsky | 48.10% | 9.66M | 13D | Mar 7, 2025 |
| Moti Investments LLC | 6.10% | 1.41M | 13G | Jul 16, 2026 |
| Knoll Capital Management, LLC | 5.20% | 630.9K | 13G | Feb 5, 2025 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.